The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has launched two referral pathways for optometrists. The RANZCO Referral Pathway for Age-related Macular Degeneration (AMD) Management and the RANZCO Referral Pathway for Diabetic Retinopathy Management were launched at the RANZCO Annual Scientific Congress in Melbourne at workshops held to share information with optometrists and GPs. They follow the launch of the RANZCO Referral Pathway for Glaucoma in August this year.
Incoming RANZCO President Associate Professor Mark Daniell said the guidelines were available to all optometrists and GPs. “RANZCO is committed to working collaboratively with optometrists, GPs and other health care professionals to ensure the most effective and efficient patient care and to improve eye health outcomes for people across Australia and New Zealand… As with the Glaucoma Pathway, the AMD and Diabetic Retinopathy Pathways have been developed with the input of both ophthalmologists and optometrists and they aim to provide a clear guide for referring patients to ophthalmologists. The pathways are being made available to all optometrists and GPs and we are keen to get feedback from those who to use them so that we can continue to build on and improve the guidelines.”
View the RANZCO Referral Pathway for AMD Management and the RANZCO Referral Pathway for Diabetic Retinopathy Management.
